Skip to main content
Official EU label nameGlossary entry 15493

LIQUIRITIN APIOSIDE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence
Markets checked
13
Markets with evidence
0
Evidence gaps
13
Resolved identifiers
2

Resolved substance identity

CAS:74639-14-8199796-12-8
Ingredient index records:
LIQUIRITIN APIOSIDE
Cosmetic functions: SKIN CONDITIONING

(2S)-2-[4-[(2S,3R,4S,5S,6R)-3-[(2R,3S,4S)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-hydroxy-2,3-dihydrochromen-4-one

1 matched or reported name
LIQUIRITIN APIOSIDE

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name LIQUIRITIN APIOSIDE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Chemical identity and properties

PubChem 2D chemical structure for CAS 199796-12-8
CAS 199796-12-8PubChem CID 124578359

Liguiritigenin-7-O-D-apiosyl-4'-O-D-glucoside

Liguiritigenin-7-O-beta-D-apiosyl-4'-O-beta-D-glucoside is a glycoside and a member of flavonoids. — ChEBI

IUPAC name
(2S)-7-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one
Molecular formula
C26H30O13
Molecular weight
550.5 g/mol
Exact mass
550.16864101 Da
XLogP3
-1.0
Topological polar surface area
205.0 Ų
Hydrogen-bond donors
7
Hydrogen-bond acceptors
13
Covalent units
1
Defined stereocentres
9

Also known as

LiquiritinapiosideCHEBI:189500HY-N2624DA-64971MS-30071CS-0023031Liguiritigenin-7-O-beta-D-apiosyl-4'-O-beta-D-glucosideLiguiritigenin-7-O-D-apiosyl-4 inverted exclamation mark -O-D-glucoside
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

PubChem 2D chemical structure for CAS 74639-14-8
CAS 74639-14-8PubChem CID 10076238

Liquiritin apioside

Liquiritin apioside is a glycoside and a member of flavonoids. — ChEBI

IUPAC name
(2S)-2-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-hydroxy-2,3-dihydrochromen-4-one
Molecular formula
C26H30O13
Molecular weight
550.5 g/mol
Exact mass
550.16864101 Da
XLogP3
-0.8
Topological polar surface area
205.0 Ų
Hydrogen-bond donors
7
Hydrogen-bond acceptors
13
Covalent units
1
Defined stereocentres
9

Also known as

UNII-8T57TH2CCD8T57TH2CCDLiquiritigenin 4'-o-apiosyl-O-glucosideLiquiritigenin-4'-o-apiosyl(1->2)glucoside4H-1-Benzopyran-4-one, 2-(4-((2-o-D-apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy)phenyl)-2,3-dihydro-7-hydroxy-, (2S)-RefChem:41016A1ETSCHEBI:191629
10 more reported names
HY-N1471liquiritigenin-4'-apiosyl-glucosideTL0002EBC-617623AC-34257AS-35047DA-75033CS-00169654-[(2S)-7-Hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-2-yl]phenyl 2-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]-beta-D-glucopyranoside4H-1-BENZOPYRAN-4-ONE, 2-(4-((2-O-D-APIO-.BETA.-D-FURANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)PHENYL)-2,3-DIHYDRO-7-HYDROXY-, (2S)-
External database identifiers

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Take this record further

Screen in a formulaOpen standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision